{
  "id": 15167460,
  "title": "Gilead chief comm & corp aff officer sells $468,660 in GILD shares",
  "url": "https://urgent.news/2026/10/17/gilead-chief-comm-corp-aff-officer-sells-468-660-in-gild-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-17T08:46:09.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/gilead-chief-comm--corp-aff-officer-sells-468660-in-gild-shares-93CH-4955348"
  },
  "original_language": "en",
  "account": "Gilead Sciences Chief Communications & Corporate Affairs Officer Johanna Mercier sold 3,000 shares of the company's common stock on October 15, 2026, according to wire material. The shares were sold at a price of $156.22 each, resulting in a total transaction value of $468,660. The sale was conducted in accordance with a pre-established Rule 10b5-1 trading plan that had been approved on February 20, 2025. The transaction occurred as Gilead's stock was trading at a price near its 52-week high of $160.51, with shares having delivered a return of 29.5% year-to-date. Following the sale, Ms. Mercier continues to own 113,684 shares of Gilead Sciences common stock. Gilead Sciences, a $195 billion biotechnology company, has a history of raising its dividend for 11 consecutive years and currently offers a dividend yield of 2.1%. However, according to InvestingPro analysis, the company appears overvalued at its current stock price. Investors looking for more detailed insights can access additional ProTips and comprehensive Pro Research Reports on the InvestingPro platform covering over 1,400 US stocks.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}